Milestone Pharmaceuticals Inc.
MIST
$1.34
$0.010.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.07M | -17.41M | -11.92M | -12.97M | -20.76M |
| Total Depreciation and Amortization | 56.00K | 615.00K | 25.00K | 28.00K | 27.00K |
| Total Amortization of Deferred Charges | 117.00K | 115.00K | 109.00K | 106.00K | 102.00K |
| Total Other Non-Cash Items | 5.30M | 3.84M | 2.11M | 2.15M | 2.10M |
| Change in Net Operating Assets | 4.54M | 63.00K | -69.00K | -1.89M | 4.58M |
| Cash from Operations | -16.05M | -12.78M | -9.75M | -12.57M | -13.95M |
| Capital Expenditure | -45.00K | -283.00K | -2.00K | -11.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -79.99M | 2.99M | -34.98M | 9.96M | 33.59M |
| Cash from Investing | -80.03M | 2.70M | -34.98M | 9.94M | 33.58M |
| Total Debt Issued | 75.00M | -- | -- | -- | -- |
| Total Debt Repaid | -11.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 19.37M | 36.43M | 46.35M | 36.00K | 140.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 2.57M | -- | -- |
| Cash from Financing | 94.35M | 36.43M | 48.92M | 36.00K | 140.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.73M | 26.36M | 4.19M | -2.59M | 19.77M |